Parallax Volatility Advisers, L.P. Catalyst Pharmaceuticals, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $291,226 - $457,857	25,324 Added 6577.66%	25,709 $345,000
Q1 2023 May 15, 2023	BUY	$14.34 - $21.05 $5,520 - $8,104	385 New	385 $6,000
Q1 2018 May 15, 2018	SELL	$2.39 - $4.01 $25,797 - $43,283	-10,794 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $27,092 - $47,493	10,794	10,794 $42,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.